Search Results 751-760 of 15919 for SC
... SC, Lopez-Lopez V, Nassar A, Hoogwater FJH, Vibert E, De Oliveira ML, Cherqui D, Porte RJ, Magliocca JF, Fischer L, Fondevila C, Zieniewicz K, Ramirez P ...
Has received subcutaneously (SC) golimumab, adalimumab, or certolizumab pegol within 6 weeks of the first study agent administration; Has received etanercept ...
Learn about the radiology expertise and services offered at Mayo Clinic to solve the most serious and complex medical questions for people who turn to the ...
The purpose of this study is to demonstrate pharmacokinetic non-inferiority for nivolumab + relatlimab FDC SC (fixed-dose combination for subcutaneous ...
SVT is a heart rhythm disorder that causes a very fast or erratic heartbeat. The heart may beat more than 150 times a minute. Know the symptoms and when ...
... SC. Acute infection of Viabahn stent graft in the popliteal artery. J Vasc Surg Cases Innov Tech. 2017 Jun; 3 (2):69-73 Epub 2017 Apr 25. View PubMed; Palraj ...
Initiation, discontinuation, or change in the dosage regimen of SC immunotherapy (SCIT). Patients on a stable dose of these medications for at least 1 year ...
... SC, Folpe AL. Klotho Overexpression Is Frequently Associated With Upstream Rearrangements in Fusion-Negative Phosphaturic Mesenchymal Tumors of Bone and ...
The purpose of this study is to evaluate the effectiveness, safety, and pharmacokinetics of mosunetuzumab subcutaneous (SC) formulation in participants with ...
MD Medical University of South Carolina; BS University of South Carolina. src="/-/media/kcms/gbs/research/images/. Clinical Studies. Learn about clinical trials ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.